Effect of chemotherapy on plasma FXIII level and its correlation with post-chemotherapy hemorrhage events in bone marrow suppression period

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023166

Enrollment

Unknown

Registered

2019-05-14

Start date

2019-05-01

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute leukemia

Interventions

Group 1:chemotherapy

Group 2:Healthy adults

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In the Department of Hematology, first Hospital of Lanzhou University, 100 patients with acute leukemia were treated with complete hematological remission, aged 18 to 70 years.

Exclusion criteria

Exclusion criteria: 1. Severe hepatic and renal failure. 2. Taking drugs affecting coagulation function. 3. Clotting function screening positive. 4. Death or loss of patients before complete remission of bone marrow.

Design outcomes

Primary

Measure	Time frame
factor XIII;	—

Countries

China

Contacts

Public ContactZijian Li

Division of Hematology, The First Hospital of Lanzhou University

lizijian@live.com+86 18993115461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026